UTHR Long Call Strategy
UTHR (United Therapeutics Corporation), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin analogue treprostinil to enhance the exercise ability in PAH patients and pulmonary hypertension associated with interstitial lung disease (PH-ILD); Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing Tyvaso DPI, a dry powder inhalation form of Tyvaso; Remunity Pump, a small, lightweight, durable pump and separate controller; RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Tyvaso PERFECT and TETON studies, which are the studies of Tyvaso in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
UTHR (United Therapeutics Corporation) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $24.60B, a trailing P/E of 19.58, a beta of 0.60 versus the broader market, a 52-week range of 272.12-609.35, average daily share volume of 559K, a public-listing history dating back to 1999, approximately 1K full-time employees. These structural characteristics shape how UTHR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.60 indicates UTHR has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long call on UTHR?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current UTHR snapshot
As of May 15, 2026, spot at $567.93, ATM IV 32.70%, IV rank 15.85%, expected move 9.37%. The long call on UTHR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on UTHR specifically: UTHR IV at 32.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a UTHR long call, with a market-implied 1-standard-deviation move of approximately 9.37% (roughly $53.24 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated UTHR expiries trade a higher absolute premium for lower per-day decay. Position sizing on UTHR should anchor to the underlying notional of $567.93 per share and to the trader's directional view on UTHR stock.
UTHR long call setup
The UTHR long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With UTHR near $567.93, the first option leg uses a $570.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed UTHR chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 UTHR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $570.00 | $23.05 |
UTHR long call risk and reward
- Net Premium / Debit
- -$2,305.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$2,305.00
- Breakeven(s)
- $593.05
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
UTHR long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on UTHR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$2,305.00 |
| $125.58 | -77.9% | -$2,305.00 |
| $251.15 | -55.8% | -$2,305.00 |
| $376.72 | -33.7% | -$2,305.00 |
| $502.30 | -11.6% | -$2,305.00 |
| $627.87 | +10.6% | +$3,481.68 |
| $753.44 | +32.7% | +$16,038.81 |
| $879.01 | +54.8% | +$28,595.95 |
| $1,004.58 | +76.9% | +$41,153.09 |
| $1,130.15 | +99.0% | +$53,710.22 |
When traders use long call on UTHR
Long calls on UTHR express a bullish thesis with defined risk; traders use them ahead of UTHR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
UTHR thesis for this long call
The market-implied 1-standard-deviation range for UTHR extends from approximately $514.69 on the downside to $621.17 on the upside. A UTHR long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current UTHR IV rank near 15.85% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on UTHR at 32.70%. As a Healthcare name, UTHR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to UTHR-specific events.
UTHR long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. UTHR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move UTHR alongside the broader basket even when UTHR-specific fundamentals are unchanged. Long-premium structures like a long call on UTHR are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current UTHR chain quotes before placing a trade.
Frequently asked questions
- What is a long call on UTHR?
- A long call on UTHR is the long call strategy applied to UTHR (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With UTHR stock trading near $567.93, the strikes shown on this page are snapped to the nearest listed UTHR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are UTHR long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the UTHR long call priced from the end-of-day chain at a 30-day expiry (ATM IV 32.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$2,305.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a UTHR long call?
- The breakeven for the UTHR long call priced on this page is roughly $593.05 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current UTHR market-implied 1-standard-deviation expected move is approximately 9.37%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on UTHR?
- Long calls on UTHR express a bullish thesis with defined risk; traders use them ahead of UTHR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current UTHR implied volatility affect this long call?
- UTHR ATM IV is at 32.70% with IV rank near 15.85%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.